SPEDRA 200 mg, tablets 4 tablets
Active ingredients: Avanafil
Commercialized according to BDPMDispensing in France: Prescription only
Tablet4 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPEDRA 200 mg, comprimés
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène aluminium de 4 comprimé(s)
- Marketing authorisation holder
- PHOENIX LABS (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 4 Apr 2014
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66839572CIP72759568CIP133400927595684Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AVANAFILcomprimé | 200 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.